GOOGL
70
-2
DUK
62
-2
OI
37
4
VRSK
84
-5
KMI
59
4
IBM
78
4
AEE
38
-12
A
24
-3
TRV
50
-2
MPC
47
3
UPS
50
4
DOW
54
2
UNP
55
6
HBAN
48
4
MCK
66
-4
C
46
3
COF
64
5
THC
67
-6
VMC
60
3
JBHT
49
6
GOOGL
70
-2
DUK
62
-2
OI
37
4
VRSK
84
-5
KMI
59
4
IBM
78
4
AEE
38
-12
A
24
-3
TRV
50
-2
MPC
47
3
UPS
50
4
DOW
54
2
UNP
55
6
HBAN
48
4
MCK
66
-4
C
46
3
COF
64
5
THC
67
-6
VMC
60
3
JBHT
49
6
Financhill
Back

Marinus Pharmaceuticals Vs. Arcutis Biotherapeutics Industry Stock Comparison

Sell
28

MRNS
Marinus Pharmaceuticals

Last Price:
1.29
Seasonality Move:
31.72%
Sell
48

ARQT
Arcutis Biotherapeutics

Last Price:
9.57
Seasonality Move:
-22.37%
Sell
28
Marinus Pharmaceuticals (MRNS) is a Sell

Is Marinus Pharmaceuticals a Buy, Sell or Hold?

  • The current Marinus Pharmaceuticals [MRNS] share price is $1.17. The Score for MRNS is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • MRNS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
Arcutis Biotherapeutics (ARQT) is a Sell

Is Arcutis Biotherapeutics a Buy, Sell or Hold?

  • The current Arcutis Biotherapeutics [ARQT] share price is $9.29. The Score for ARQT is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • ARQT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

MRNS Stock Price Chart

What is Marinus Pharmaceuticals's stock price today?

  • The Marinus Pharmaceuticals share price today is $1.17
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MRNS is experiencing slight selling pressure.

ARQT Stock Price Chart

What is Arcutis Biotherapeutics's stock price today?

  • The Arcutis Biotherapeutics share price today is $9.29
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ARQT is experiencing slight selling pressure.

MRNS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.17 Sell
Relative Strength Index (14 RSI): 25.72 Sell
Chaikin Money Flow: -1752708 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.32 - 1.52) Sell
Bollinger Bands (100): (1.15 - 8.99) Sell

ARQT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.17 Buy
Relative Strength Index (14 RSI): 56.65 Buy
Chaikin Money Flow: -123216 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.85 - 9.13) Buy
Bollinger Bands (100): (7.81 - 10.55) Buy

MRNS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.31 Sell
20-day SMA: 1.42 Sell
50-day SMA: 1.41 Sell
200-day SMA: 6.57 Sell
8-day EMA: 1.3 Sell
20-day EMA: 1.4 Sell
50-day EMA: 2.3 Sell
200-day EMA: 5.62 Sell

ARQT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8.92 Buy
20-day SMA: 8.4 Buy
50-day SMA: 8.58 Buy
200-day SMA: 6.38 Buy
8-day EMA: 9.02 Buy
20-day EMA: 8.72 Buy
50-day EMA: 8.71 Buy
200-day EMA: 8.21 Buy

Marinus Pharmaceuticals Earnings Growth & MRNS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.20 per share, an increase next quarter of $0.24 per share, an increase this year of $0.58 per share, and an increase next year of $0.88 per share.

Arcutis Biotherapeutics Earnings Growth & ARQT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.25 per share, and an increase next year of $0.48 per share.

Marinus Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Arcutis Biotherapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):